Novo Nordisk’s chief scientific officer Marcus Schindler led the keynote address at ELRIG Drug Discovery 2024 in London, UK.

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might ...

ImmunoPrecise Antibodies, an AI-driven biotherapeutic research and technology company, has entered into a material transfer ...

Enara Bio has raised $32.5m in a Series B financing round to advance its platform shining a light on cancer-specific antigens ...

Eli Lilly has announced a $4.5bn investment to establish the Lilly Medicine Foundry for drug production and manufacturing ...

Novaliq and Laboratoires Théa have announced approval from the European Commission (EC) for Vevizye (ciclosporin 0.1% eye ...

Gilead Sciences has announced the signing of voluntary licencing agreements with six generic pharmaceutical manufacturers to ...

Sofgen, a supplier of softgel technologies for generics, prescription drugs, OTC products and specialised nutraceuticals, ...

GlobalData’s report assesses the drugs in the Protein Kinase C Theta Type pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

GlobalData’s report assesses the drugs in the Serine Protein Kinase ATM pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

GlobalData’s report assesses the drugs in the Retinoic Acid Receptor Gamma pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.